Skip to main content
SpringerLink
Log in

Nitisinone

Ntbc, Orfadin®

  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

References

  1. Hall MG, Wilks MF, McLean Provan W, Eksborg S, Lumholtz B. Pharmacokinetics and pharmacodynamics of NTBC (2-(2-nitro-4-fluoromethylbenzoyl)-I,3-cyclohexanedione) and mesotrione, inhibitors of 4-hydroxyphenyl pyruvate dioxygenase (HPPD) following a single dose to healthy male volunteers. British Journal of Clinical Pharmacology 52: 169–177, Aug 2001

    Article  PubMed  CAS  Google Scholar 

  2. Editorial. New treatment for tyrosinaemia. Lancet 340: 822–823, 3 Oct 1992

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nitisinone. Drugs R&D 3, 139–140 (2002). https://doi.org/10.2165/00126839-200203020-00017

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-200203020-00017

Keywords

Search

Navigation